Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study

BACKGROUND: Anti-tuberculosis therapy requires at least six-month treatment with continuous administration of combined antibiotics, including isoniazid, rifampicin, pyrazinamide, and ethambutol. The long-term exposure to antibiotics could cause consequent changes in gut microbiota, which may alter t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pulm Med
Main Authors: Shi, Wenpei, Hu, Yi, Zheng, Xubin, Ning, Zhu, Wu, Meiying, Xia, Fan, Prast-Nielsen, Stefanie, Hu, Yue O. O., Xu, Biao
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849301/
https://ncbi.nlm.nih.gov/pubmed/31711450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0981-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki